Levocetirizine dihydrochloride

Suppliers

Names

[ CAS No. ]:
130018-87-0

[ Name ]:
Levocetirizine dihydrochloride

[Synonym ]:
Xyzall
EINECS 200-659-6
(R)-Cetirizine Dihydrochloride
Levocetirizine dihydrochloride
(2-{4-[(R)-(4-Chlorphenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)essigsäuredihydrochlorid
MFCD07366507
(-)-Cetirizine dihydrochloride
Levocetirizine 2HCl
Xusal
(2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl}ethoxy)acetic acid dihydrochloride
2-[2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride
Xyzal
acide (2-{4-[(R)-(4-chlorophényl)(phényl)méthyl]pipérazin-1-yl}éthoxy)acétique dichlorhydrate
acetic acid, [2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride
Acetic acid, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, hydrochloride (1:2)
(2-{4-[(R)-(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid dihydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
542.1ºC at 760 mmHg

[ Melting Point ]:
215-220ºC

[ Molecular Formula ]:
C21H27Cl3N2O3

[ Molecular Weight ]:
461.810

[ Flash Point ]:
281.6ºC

[ Exact Mass ]:
460.108734

[ PSA ]:
53.01000

[ LogP ]:
4.62800

[ Storage condition ]:
room temp

MSDS

Safety Information

[ Symbol ]:

GHS07, GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H400

[ Precautionary Statements ]:
P273

[ Hazard Codes ]:
Xn,N

[ Risk Phrases ]:
22-50/53

[ Safety Phrases ]:
60-61

[ RIDADR ]:
UN 3077 9 / PGIII

[ HS Code ]:
2933990090

Customs

[ HS Code ]: 2933599090

[ Summary ]:
2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Rapid chiral separation of racemic cetirizine in human plasma using subcritical fluid chromatography-tandem mass spectrometry.

J. Pharm. Biomed. Anal. 117 , 380-9, (2015)

A method for fast chiral separation of cetirizine and quantitation of levocetirizine in human plasma using subcritical fluid chromatography with tandem mass spectrometry was developed and validated. T...

Development and characterization of pharmacokinetic parameters of fast-dissolving films containing levocetirizine.

Sci. Pharm. 80 , 779-87, (2012)

A fast-dissolving film containing levocetirizine, a non-sedative antihistamine drug, was developed using pullulan, xanthan gum, propylene glycol, and tween 80 as the base materials. The drug content o...


More Articles


Related Compounds

  • Levocetirizine
  • Levocetirizine Impurity 4
  • (S)-Cetirizine Dihydrochloride
  • Piminodine Dihydrochloride
  • 1400W dihydrochloride
  • Furosine dihydrochloride
  • (R)-2-(3,5-Difluorophenyl)-2-(methylamino)ethan-1-ol
  • 5-[(3,5-dimethyl-4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)sulfonyl]pyridine-2-carbonitrile
  • 1-Ethenesulfonylpiperidin-4-ylamine hydrochloride
  • 4-[(2R,6R)-2-(2-Methoxyphenyl)-6-methylpiperidine-1-carbonyl]pyridine-2-carbonitrile
  • 3-(3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl)-6-fluoroquinolin-4(1H)-one
  • 2-{N-[(oxolan-2-yl)methyl]acetamido}acetic acid
  • 3-[(3S,4R)-3-Cyano-4-phenylpyrrolidin-1-yl]sulfonylpyridine-2-carbonitrile
  • N-(1-Cyanocyclohexyl)-2-[(2R)-2-methyl-4-(oxan-4-yl)piperazin-1-yl]acetamide
  • 3-(3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl)quinolin-4(1H)-one
  • 3-(2-Pyridin-3-ylpyrrolidin-1-yl)sulfonylpyridine-2-carbonitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.